Publication | Open Access
EGFR Amplified and Overexpressing Glioblastomas and Association With Better Response to Adjuvant Metronomic Temozolomide
40
Citations
23
References
2015
Year
EGFR-amplified/overexpressing glioblastomas strongly benefit from metronomic temozolomide-based therapies.
| Year | Citations | |
|---|---|---|
Page 1
Page 1